We discuss CLS' valuation, performance metrics, and future outlook, advising caution amidst potential challenges in FY2025.

Discover how the PBoC's actions are impacting Chinese equities and why selling volatility may be a smart move in the current ...

An explainer and analysis of the shift from traditional manufacturing to tech-driven operations. Click here to read.

There are strategies to maintain income growth amidst market risks. See here for our recommendation of preferred stocks for ...

DXPE stock is a good buy with strong growth prospects and strategic acquisitions. Read here for highlights on its Q2 revenue ...

Despite the recent rally, Cato stock is down 18% since May 2023. Valuation metrics are attractive, but bottom-line ...

Historically, as long as the economy remains stable (and out of a recession), rate cuts tend to support smaller- and mid-cap ...

In today's market, focusing on dependable dividend stocks is essential. Read here for 2 standout dividend stocks for ...

Medical Properties Trust faces challenges, primarily due to its over-reliance on its largest tenant, Steward, which led to ...

Brown-Forman's growth has halted due to market challenges, underperformance, and high stock valuation despite weak ...

Monthly payers like DIA, JEPI, JEPQ, and SPHY provide consistent income, making them attractive for income-focused investors.

Discover potential for outperformance in international investing with the Main International ETF, despite risks like currency ...